These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19538221)

  • 1. Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic disease.
    Tanne D; Tenenbaum A; Boyko V; Benderly M; Fisman EZ; Matas Z; Adler Y; Behar S
    Eur J Neurol; 2009 Nov; 16(11):1217-23. PubMed ID: 19538221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease.
    Tenenbaum A; Adler Y; Boyko V; Tenenbaum H; Fisman EZ; Tanne D; Lapidot M; Schwammenthal E; Feinberg MS; Matas Z; Motro M; Behar S
    Am Heart J; 2007 Apr; 153(4):559-65. PubMed ID: 17383294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and acute coronary syndrome.
    Caccamo G; Bonura F; Bonura F; Vitale G; Novo G; Evola S; Evola G; Grisanti MR; Novo S
    Atherosclerosis; 2010 Aug; 211(2):672-5. PubMed ID: 20466373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of hypertension modifies the impact of insulin resistance on incident cardiovascular disease in a Middle Eastern population: the Tehran Lipid and Glucose Study.
    Ghoreishian H; Tohidi M; Derakhshan A; Hajsheikholeslami F; Azizi F; Kazempour-Ardebili S; Hadaegh F
    Diabet Med; 2015 Oct; 32(10):1311-8. PubMed ID: 25711172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors.
    Kitta Y; Nakamura T; Uematsu M; Sugamata W; Deyama J; Fujioka D; Saito Y; Kawabata K; Obata JE; Kugiyama K
    J Cardiol; 2013 Dec; 62(6):348-53. PubMed ID: 23810069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome.
    Carnevale Schianca GP; Sainaghi PP; Castello L; Rapetti R; Limoncini AM; Bartoli E
    Diabetes Metab Res Rev; 2006; 22(2):111-7. PubMed ID: 16052601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac autonomic function and insulin resistance for the development of hypertension: a six-year epidemiological follow-up study.
    Wu JS; Yang YC; Lu FH; Lin TS; Chen JJ; Huang YH; Yeh TL; Chang CJ
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1216-22. PubMed ID: 23419733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
    J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease.
    Koren-Morag N; Goldbourt U; Graff E; Tanne D
    J Neurol Sci; 2008 Jul; 270(1-2):82-7. PubMed ID: 18377938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sample.
    Sung KC; Lim S; Rosenson RS
    Am J Hypertens; 2011 Sep; 24(9):1041-5. PubMed ID: 21614095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance.
    Esteghamati A; Ashraf H; Esteghamati AR; Meysamie A; Khalilzadeh O; Nakhjavani M; Abbasi M
    Diabetes Res Clin Pract; 2009 Jun; 84(3):279-87. PubMed ID: 19359063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance.
    Stange R; Pflugbeil C; Michalsen A; Uehleke B
    Forsch Komplementmed; 2013; 20(6):421-6. PubMed ID: 24434756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease.
    Solymoss BC; Bourassa MG; Lespérance J; Levesque S; Marcil M; Varga S; Campeau L
    Coron Artery Dis; 2003 May; 14(3):207-12. PubMed ID: 12702923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nasal continuous positive airway pressure treatment on insulin resistance and ghrelin levels in non-diabetic apnoeic patients with coronary heart disease.
    Yang D; Liu ZH; Zhao Q; Luo Q
    Chin Med J (Engl); 2013; 126(17):3316-20. PubMed ID: 24033956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
    Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
    Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome.
    Nigam A; Frasure-Smith N; Lespérance F; Julien P
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):264-70. PubMed ID: 18804984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
    Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study.
    Barzilay JI; Blaum C; Moore T; Xue QL; Hirsch CH; Walston JD; Fried LP
    Arch Intern Med; 2007 Apr; 167(7):635-41. PubMed ID: 17420420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.